Patents by Inventor André Ulmann

André Ulmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250281504
    Abstract: A method of ameliorating a disorder of insulin sensitivity, which entails administering an amount of one or more glucocorticoid receptor antagonists effective to ameliorate the disorder with no more than an acceptable activation of the hypothalamic-pituitary-adrenal axis, such that 24 hour serum or urine cortisol levels do not exceed about two to three times the upper normal limit, respectively.
    Type: Application
    Filed: November 19, 2024
    Publication date: September 11, 2025
    Inventors: Lynnette K. Nieman, Arnold L. Newman, André Ulmann
  • Publication number: 20150320766
    Abstract: The invention relates to a copper contraceptive intrauterine system (IUS) with a flexible frame, which system is further capable of releasing a selective progesterone receptor modulator (SPRM), such as ulipristal acetate, for reducing or preventing bleeding side effects.
    Type: Application
    Filed: December 13, 2013
    Publication date: November 12, 2015
    Inventors: André ULMANN, Erin GAINER, Delphine LEVY, Christine SEGUIN, Florian BATTUNG, Regine SITRUK-WARE
  • Patent number: 9180131
    Abstract: The invention relates to a method of contraception, which method comprises administering to a woman in need thereof an emergency contraception during one or two days, followed by a prolonged low dosage contraceptive treatment until next menstrual period.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: November 10, 2015
    Assignee: LABORATOIRE HRA PHARMA
    Inventors: Erin Gainer, André Ulmann, Luc Massart, Héléne Guillard
  • Patent number: 8652543
    Abstract: Compositions are disclosed containing, as active ingredients, an extract of Allium species, an extract of Citrus species and either an extract of Paullinia species and an extract of Theobroma species, or an extract of Salix species and zinc sulphate, and the method of preparation of these compositions, and cosmetic and/or pharmaceutical application of these compositions.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: February 18, 2014
    Assignee: Legacy Healthcare Holding Ltd.
    Inventors: André Ulmann, Jean-Frédéric Laville
  • Patent number: 8361522
    Abstract: Compositions are disclosed containing, as active ingredients, an extract of Allium species, an extract of Citrus species and either an extract of Paullinia species and an extract of Theobroma species, or an extract of Salix species and zinc sulphate, and the method of preparation of these compositions, and cosmetic and/or pharmaceutical application of these compositions.
    Type: Grant
    Filed: February 8, 2008
    Date of Patent: January 29, 2013
    Assignee: Legacy Healthcare Holding Ltd
    Inventors: André Ulmann, Jean-Frédéric Sturer
  • Patent number: 8299050
    Abstract: The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17?-acetoxy-11?-[4-N,N-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/or for reducing the size of uterine fibroids.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: October 30, 2012
    Assignees: Laboratoire HRA-Pharma, The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Lynnette Nieman, André Ulmann, Diana Blithe, Erin Gainer
  • Publication number: 20120064174
    Abstract: The present teachings provide methods for stimulating the hair growth on a human head including simultaneous administration: a) by oral or transdermal route of a composition containing a 5-alpha-reductase inhibitor or a peripheral vasodilator, and b) by topical route of a composition containing as active ingredient an extract of Allium species, an extract of Citrus species and either an extract of Paullinia species and an extract of Theobroma species or an extract of Salix species and zinc sulfate.
    Type: Application
    Filed: August 2, 2011
    Publication date: March 15, 2012
    Applicant: LEGACY HEALTHCARE HOLDING LTD.
    Inventors: Saad Harti, André Ulmann
  • Publication number: 20110245211
    Abstract: The invention relates to a method of contraception, which method comprises administering to a woman in need thereof an emergency contraception during one or two days, followed by a prolonged low dosage contraceptive treatment until next menstrual period.
    Type: Application
    Filed: December 11, 2009
    Publication date: October 6, 2011
    Inventors: Erin Gainer, André Ulmann, Luc Massart, Hélène Guillard
  • Publication number: 20100261693
    Abstract: The invention relates to a method for treating Cushing's syndrome in a patient, which method comprises administering the patient with a pharmaceutical composition comprising a glucocorticoid receptor antagonist, at least twice a day, or an extended-release composition of a glucocorticoid receptor antagonist, or a combination of a glucocorticoid receptor antagonist and a inhibitor of cortisol synthesis.
    Type: Application
    Filed: October 13, 2008
    Publication date: October 14, 2010
    Inventors: André Ulmann, Erin Gainer, François Vuillet
  • Publication number: 20100104671
    Abstract: Compositions are disclosed containing, as active ingredients, an extract of Allium species, an extract of Citrus species and either an extract of Paullinia species and an extract of Theobroma species, or an extract of Salix species and zinc sulphate, and the method of preparation of these compositions, and cosmetic and/or pharmaceutical application of these compositions.
    Type: Application
    Filed: February 8, 2008
    Publication date: April 29, 2010
    Applicant: LEGACY HEALTHCARE HOLDING LTD.
    Inventors: André Ulmann, Jean-Frédéric Sturer